v3.26.1
Consolidated Statements of Stockholders' Deficit - USD ($)
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Common Stock [Member]
Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Non controlling Interest [Member]
Balance Beginning, Amount at Dec. 31, 2024 $ 14,799,085 $ 216 $ 29 $ 35,881,552   $ 57,459 $ (26,127,313) $ 4,987,142
Shares, Outstanding, Beginning Balance at Dec. 31, 2024   21,706,939 2,899,343          
Exercise of stock options,Shares     2,084          
Exercise of stock options,Value 375     375        
Exercise of stock warrants,Shares     214,229          
Exercise of stock warrants,Value 51,408   $ 2 51,406        
Warrants issued in connection with Series C Convertible Preferred Stock 615,427     615,427        
Stock-based compensation - options 44,548     44,548        
Offering costs, Value (106,970)     (106,970)        
Net loss (incl. NCI) (3,719,621)           (3,657,042) (62,579)
Balance Ending, Amount at Mar. 31, 2025 11,684,252 $ 216 $ 31 36,486,338   57,459 (29,784,355) 4,924,563
Shares, Outstanding, Ending Balance at Mar. 31, 2025   21,706,939 3,115,656          
Balance Beginning, Amount at Dec. 31, 2024 14,799,085 $ 216 $ 29 35,881,552   57,459 (26,127,313) 4,987,142
Shares, Outstanding, Beginning Balance at Dec. 31, 2024   21,706,939 2,899,343          
Net loss (incl. NCI) (4,985,044)              
Balance Ending, Amount at Jun. 30, 2025 10,776,719 $ 216 $ 31 36,844,228   57,459 (31,020,938) 4,895,723
Shares, Outstanding, Ending Balance at Jun. 30, 2025   21,706,939 3,115,656          
Balance Beginning, Amount at Mar. 31, 2025 11,684,252 $ 216 $ 31 36,486,338   57,459 (29,784,355) 4,924,563
Shares, Outstanding, Beginning Balance at Mar. 31, 2025   21,706,939 3,115,656          
Issuance of Common Stock  for services, Value 470,759     470,759        
Stock-based compensation - options 176,916     176,916        
Offering costs, Value (289,785)     (289,785)        
Net loss (incl. NCI) (1,265,423)           (1,236,583) (28,840)
Balance Ending, Amount at Jun. 30, 2025 10,776,719 $ 216 $ 31 36,844,228   57,459 (31,020,938) 4,895,723
Shares, Outstanding, Ending Balance at Jun. 30, 2025   21,706,939 3,115,656          
Balance Beginning, Amount at Dec. 31, 2025 (634,522) $ 216 $ 34 37,661,354 $ 0 55,172 (40,705,027) 2,353,729
Shares, Outstanding, Beginning Balance at Dec. 31, 2025   21,706,939 3,364,984          
Issuance of Common Stock  for services, Value 693,659   $ 1 693,658       0
Issuance of Common Stock for services, Shares     77,776          
Exercise of stock options,Shares     4,667          
Exercise of stock options,Value 1,260   $ 1,260 1,260       0
Exercise of stock warrants,Shares   740,328 222,026          
Exercise of stock warrants,Value 986,226 $ 7 $ 2 986,217       0
Shares issued for extinguishment of interest payable,Shares     86,342          
Shares issued for extinguishment of interest payable,Value 276,475   $ 1 276,474       0
Repurchase of Common Stock,Shares         (155,375)      
Repurchase of Common Stock, Value (1,393,713)     0 $ (1,393,713)      
Stock-based compensation - options 220,932     220,932       0
Offering costs, Value (37,315)     (37,315)       0
Net loss (incl. NCI) (3,041,605)         0 (3,035,704) (5,901)
Balance Ending, Amount at Mar. 31, 2026 (2,928,603) $ 223 $ 38 39,802,580 $ (1,393,713) 55,172 (43,740,731) 2,347,828
Shares, Outstanding, Ending Balance at Mar. 31, 2026   22,447,267 3,755,795   (155,375)      
Balance Beginning, Amount at Dec. 31, 2025 $ (634,522) $ 216 $ 34 37,661,354 $ 0 55,172 (40,705,027) 2,353,729
Shares, Outstanding, Beginning Balance at Dec. 31, 2025   21,706,939 3,364,984          
Exercise of stock options,Shares 17,582              
Net loss (incl. NCI) $ (10,590,822)              
Balance Ending, Amount at Jun. 30, 2026 993,404 $ 0 $ 118 51,273,945 $ (1,393,713) 55,172 (51,215,008) 2,272,890
Shares, Outstanding, Ending Balance at Jun. 30, 2026     11,760,456   (155,375)      
Balance Beginning, Amount at Mar. 31, 2026 (2,928,603) $ 223 $ 38 39,802,580 $ (1,393,713) 55,172 (43,740,731) 2,347,828
Shares, Outstanding, Beginning Balance at Mar. 31, 2026   22,447,267 3,755,795   (155,375)      
Conversion of Preferred Stock to Common Stock upon Direct Listing, Shares   (22,447,267) 7,483,093          
Conversion of Preferred Stock to Common Stock upon Direct Listing, Value   $ (223) $ 75 148        
Corrective issuance of Common Stock, net of cost, Value 0   $ 0 0       0
Corrective issuance of Common Stock, net of cost, Shares     1,805          
Conversion of convertible notes upon Direct Listing, Shares     223,050          
Conversion of convertible notes upon Direct Listing, Value 3,791,850   $ 2 3,791,848       0
Exercise of stock options,Shares     12,915          
Exercise of stock options,Value 2,925     2,925       0
Exercise of stock warrants,Shares     84,907          
Exercise of stock warrants,Value 14,211   $ 1 14,210       0
Warrants issued in connection with Series C Convertible Preferred Stock 4,824,382     4,824,382       0
Issuance of Common Stock for services, Shares     170,766          
Issuance of Common Stock for services, Value 1,938,141   $ 2 1,938,139       0
Stock-based compensation - options 226,613     226,613       0
Offering costs, Shares     28,125          
Offering costs, Value (272,893)     (272,893)       0
Net loss (incl. NCI) (7,549,215)         0 (7,474,277) (74,938)
Balance Ending, Amount at Jun. 30, 2026 993,404 $ 0 $ 118 51,273,945 $ (1,393,713) $ 55,172 $ (51,215,008) $ 2,272,890
Shares, Outstanding, Ending Balance at Jun. 30, 2026     11,760,456   (155,375)      
Stock warrant exercise inducement $ 945,993     $ 945,993